Skip to main content

Articles

Page 1 of 15

  1. Medical insurance stands as a pivotal component within the overarching framework of public service systems. The intricate interplay between the extent of healthcare coverage and the overall well-being of the p...

    Authors: Wang Sheng and Liao Fuchong
    Citation: Cost Effectiveness and Resource Allocation 2024 22:48
  2. This survey investigates the development of day surgery in China, and analyzes the national policy support, medical service management model, disease types of day surgery, medical insurance payment methods, an...

    Authors: Dong Haihan, Zheng Changfei, Lian Hengli, Tang Ning, Zhuo Lezhen and Lin Hui
    Citation: Cost Effectiveness and Resource Allocation 2024 22:47
  3. There is some evidence that differentiated service delivery (DSD) models, which use a client-centered approach to simplify and increase access to care, improve clinical outcomes among people living with HIV (P...

    Authors: Annie Liang, Marta Wilson-Barthes and Omar Galárraga
    Citation: Cost Effectiveness and Resource Allocation 2024 22:46
  4. The rising older adult population has led to an increase in the prevalence of chronic diseases and medical expenses. Women tend to have a longer healthy life expectancy than men and are more likely to be expos...

    Authors: Sewon Park, Ji Seokmin, Hyunseo Lee, Hangseok Choi, Mankyu Choi, Munjae Lee and Mihajlo Jakovljevic
    Citation: Cost Effectiveness and Resource Allocation 2024 22:45
  5. Deep learning (DL) is a new technology that can assist prenatal ultrasound (US) in the detection of congenital heart disease (CHD) at the prenatal stage. Hence, an economic-epidemiologic evaluation (aka Cost-U...

    Authors: Gary M. Ginsberg, Lior Drukker, Uri Pollak and Mayer Brezis
    Citation: Cost Effectiveness and Resource Allocation 2024 22:44
  6. Tuberculosis (TB) is a major threat to public health, particularly in countries where the disease is highly prevalent, such as Ethiopia. Early diagnosis and treatment are the main components of TB prevention a...

    Authors: Lelisa Fekadu Assebe, Andargachew Kumsa Erena, Lemmessa Fikadu, Bizuneh Alemu, Yirgalem Shibiru Baruda and Boshen Jiao
    Citation: Cost Effectiveness and Resource Allocation 2024 22:43
  7. Hyperkalemia (HK) is frequently present in chronic kidney disease (CKD). Risk factors for HK among CKD patients include comorbidities and renin–angiotensin–aldosterone system inhibitor (RAASi) treatment. Curre...

    Authors: Ewa Stawowczyk, Thomas Ward, Ernesto Paoletti, Michele Senni and Antonio Ramirez de Arellano
    Citation: Cost Effectiveness and Resource Allocation 2024 22:42
  8. The term ‘perspective’ in the context of economic evaluations and costing studies in healthcare refers to the viewpoint that an analyst has adopted to define the types of costs and outcomes to consider in thei...

    Authors: Manit Sittimart, Waranya Rattanavipapong, Andrew J. Mirelman, Trinh Manh Hung, Saudamini Dabak, Laura E. Downey, Mark Jit, Yot Teerawattananon and Hugo C. Turner
    Citation: Cost Effectiveness and Resource Allocation 2024 22:41
  9. Early during the COVID-19 outbreak, various approaches were utilized to prevent COVID-19 introductions from incoming airport travellers. However, the costs and effectiveness of airport-specific interventions h...

    Authors: Geofrey Amanya, Michael L. Washington, Daniel Kadobera, Migisha Richard, Alex Ndyabakiira and Julie Harris
    Citation: Cost Effectiveness and Resource Allocation 2024 22:40
  10. Twin-twin transfusion syndrome (TTTS) affects 10–15% of monochorionic twin pregnancies. Without treatment, their mortality rates would be considerable. There are differences in survival rate between different ...

    Authors: Zhila Najafpour, Kamran Shayanfard, Negar Aghighi and Najmieh Saadati
    Citation: Cost Effectiveness and Resource Allocation 2024 22:39
  11. Surgical staplers have been widely used to facilitate surgeries, and this study aimed to examine the real-world effectiveness of a new powered stapling system with Gripping Surface Technology (GST) on intraope...

    Authors: Honghai Guo, Tao Zheng, Yecheng Lin, Tiange Tang, Zhidong Zhang, Dong Wang, Xuefeng Zhao, Yu Liu, Bibo Tan, Peigang Yang, Yuan Tian, Yong Li and Qun Zhao
    Citation: Cost Effectiveness and Resource Allocation 2024 22:38
  12. Prostate cancer (PCa) causes a substantial health and financial burden worldwide, underscoring the need for efficient mass screening approaches. This study attempts to evaluate the Net Cost-Benefit Index (NCBI...

    Authors: Hiro Farabi, Najmeh Moradi, Aziz Ahmadzadeh, Seyed Mohammad Kazem Aghamir, Abdolreza Mohammadi and Aziz Rezapour
    Citation: Cost Effectiveness and Resource Allocation 2024 22:37
  13. Ethiopia, like many low-income countries, faces significant challenges in providing accessible and affordable healthcare to its population. Health expenditure is a critical factor in determining the quality an...

    Authors: Yawkal Tsega, Abel Endawkie, Shimels Derso Kebede, Natnael Kebede, Mengistu Mera Mihiretu, Ermias Bekele, Kokeb Ayele, Lakew Asmare, Fekade Demeke Bayou and Mastewal Arefaynie
    Citation: Cost Effectiveness and Resource Allocation 2024 22:36
  14. To ensure the long-term sustainability of its Community-Based Health Insurance scheme, the Government of Rwanda is working on using Health Technology Assessment (HTA) to prioritize its resources for health. Th...

    Authors: Cassandra Nemzoff, Nurilign Ahmed, Tolulope Olufiranye, Grace Igiraneza, Ina Kalisa, Sukrit Chadha, Solange Hakiba, Alexis Rulisa, Matiko Riro, Kalipso Chalkidou and Francis Ruiz
    Citation: Cost Effectiveness and Resource Allocation 2024 22:35
  15. It has been estimated that vaccines can accrue a relatively large part of their value from patient and carer productivity. Yet, productivity value is not commonly or consistently considered in health economic ...

    Authors: Margherita Neri, Janne C. Mewes, Fernando Albuquerque de Almeida, Sophia Stoychev, Nadia Minarovic, Apostolos Charos, Kimberly M. Shea and Lotte M.G. Steuten
    Citation: Cost Effectiveness and Resource Allocation 2024 22:34
  16. Although economic evaluations (EEs) have been increasingly applied to medical devices, little discussion has been conducted on how the different health realities of specific populations may impact the applicat...

    Authors: Edgar Mascarenhas, Luís Silva Miguel, Mónica D Oliveira and Ricardo M Fernandes
    Citation: Cost Effectiveness and Resource Allocation 2024 22:33
  17. Sacituzumab govitecan (SG) has recently been approved in China for the post-line treatment of metastatic triple-negative breast cancer (mTNBC). SG substantially improves progression-free survival and overall s...

    Authors: Yilai Wu, Shanshan Hu, Xiaolin Liu, Yang Chen, Jiajie Luan and Shuowen Wang
    Citation: Cost Effectiveness and Resource Allocation 2024 22:32
  18. The labor supply of nurses, as one of the main healthcare workers, is an important issue in health human resources planning in all health systems. Finding the factors affecting it, could help policymakers to ...

    Authors: Ali Keshavarzi, Sajad Delavari, Farhad Lotfi, Zahra Goudarzi, Faezeh Bashiri and Mohsen Bayati
    Citation: Cost Effectiveness and Resource Allocation 2024 22:31
  19. Many advantages of hospital at home (HaH), as a modality of acute care, have been highlighted, but controversies exist regarding the cost-benefit trade-offs. The objective is to assess health outcomes and anal...

    Authors: Carme Hernandez, Carme Herranz, Erik Baltaxe, Nuria Seijas, Rubèn González-Colom, Maria Asenjo, Emmanuel Coloma, Joaquim Fernandez, Emili Vela, Gerard Carot-Sans, Isaac Cano, Josep Roca and David Nicolas
    Citation: Cost Effectiveness and Resource Allocation 2024 22:30
  20. Integrated care, in particular the ‘Blended Collaborative Care (BCC)’ strategy, may have the potential to improve health-related quality of life (HRQoL) in multimorbid patients with heart failure (HF) and psyc...

    Authors: Lisa Derendorf, Stephanie Stock, Dusan Simic, Arim Shukri, Christine Zelenak, Jonas Nagel, Tim Friede, Birgit Herbeck Belnap, Christoph Herrmann-Lingen, Susanne S. Pedersen, Jan Sørensen and Dirk Müller and on behalf of the ESCAPE consortium
    Citation: Cost Effectiveness and Resource Allocation 2024 22:29
  21. The aim of the study was to estimate the long-term cost-effectiveness of the Support and Treatment After Replacement (STAR) care pathway for chronic pain after total knee replacement compared with usual postop...

    Authors: Sophie Cole, Sian Noble, Rachael Gooberman-Hill and Rafael Pinedo-Villanueva
    Citation: Cost Effectiveness and Resource Allocation 2024 22:28
  22. The medical pricing system strongly influences physicians’ job satisfaction and patient health outcomes. This study aimed to investigate the current relative value unit (RVU)-based pricing and utility of patie...

    Authors: Yoon Hyo Choi, Tae Hun Kwon, Chin Youb Chung, Naun Jeong and Kyoung Min Lee
    Citation: Cost Effectiveness and Resource Allocation 2024 22:27
  23. Chronic diseases, or non-communicable diseases (NCD), are conditions of long duration and often influenced and contributed by complex interactions of several variables, including genetic, physiological, enviro...

    Authors: George Lin, Kalin Werner, Ada Alqunaiebet, Mariam M. Hamza, Norah Alkanhal, Reem F. Alsukait, Amaal Alruwaily, Severin Rakic, Volkan Cetinkaya, Christopher H. Herbst and Tracy Kuo Lin
    Citation: Cost Effectiveness and Resource Allocation 2024 22:26
  24. The treatment of kidney disease, including hemodialysis, poses challenges in healthcare and finances. Despite limited data on hemodialysis costs and determinants in Ethiopia, existing literature indicates a pa...

    Authors: Tiruneh Amsalu Baye, Hamelmal Gebeyehu, Mahteme Bekele, Semira Abdelmenan, Tigistu Adamu Ashengo and Berhanu Mengistu
    Citation: Cost Effectiveness and Resource Allocation 2024 22:25
  25. There is growing evidence to support the benefits of transcatheter aortic valve implantation (TAVI) over surgical aortic valve replacement (SAVR) in patients with symptomatic severe aortic stenosis (sSAS) who ...

    Authors: Rob Eerdekens, Suzanne Kats, Janneke PC Grutters, Michelle Green, Judith Shore, Pascal Candolfi, Wija Oortwijn, Pim Van Der Harst and Pim Tonino
    Citation: Cost Effectiveness and Resource Allocation 2024 22:24
  26. Economic evaluations play an important role in the development and implementation of healthcare innovations. For pharmaceutical products, the methodologies used are laid down in guidelines, whereas for medical...

    Authors: C. van Lieshout, G. W. J. Frederix and L. Schoonhoven
    Citation: Cost Effectiveness and Resource Allocation 2024 22:23
  27. Stroke readmissions are considered a marker of health quality and may pose a burden to healthcare systems. However, information on the costs of post-stroke readmissions has not been systematically reviewed.

    Authors: Pedro Abreu, Manuel Correia, Elsa Azevedo, Bernardo Sousa-Pinto and Rui Magalhães
    Citation: Cost Effectiveness and Resource Allocation 2024 22:22
  28. Triple-negative breast cancer (TNBC) is responsible for 10–20% cases of breast cancer and is resulting in rising healthcare costs. Thus, health-economic evaluations are needed to relate clinical outcomes and c...

    Authors: Amelie Wickmann, Melina Sophie Kurte, Julia Jeck, Luisa Camacho, Dennis Klinkhammer, Florian Kron and Robert Dengler
    Citation: Cost Effectiveness and Resource Allocation 2024 22:21
  29. The emergence of high-priced potential cures has sparked significant health policy discussions in South Korea, where the healthcare system is funded through a single-payer National Health Insurance model. We c...

    Authors: Jihyung Hong, Eun-Young Bae, Hye-Jae Lee, Tae-Jin Lee and Philip Clarke
    Citation: Cost Effectiveness and Resource Allocation 2024 22:20
  30. Chronic obstructive pulmonary disease (COPD) is associated with a high readmission rate and poses a significant disease burden. South Korea initiated pilot projects on transitional care services (TCS) to reduc...

    Authors: Yu Seong Hwang, Woo Jin Kim, Tae Hyun Kim, Yukyung Park, Su Mi Jung and Heui Sug Jo
    Citation: Cost Effectiveness and Resource Allocation 2024 22:19
  31. This study aimed to evaluate the cost-effectiveness of a telehealth coaching intervention to prevent gestational diabetes mellitus (GDM) and to calculate the breakeven point of preventing GDM.

    Authors: Susan de Jersey, Syed Afroz Keramat, Angela Chang, Nina Meloncelli, Taylor Guthrie, Elizabeth Eakin and Tracy Comans
    Citation: Cost Effectiveness and Resource Allocation 2024 22:18
  32. The prominent efficacy in terms of increasing progression-free survival (PFS) of Daratumumab, Lenalidomide and dexamethasone (DRd) triplet therapy versus Carfilzomib, Lenalidomide and dexamethasone (KRd) was p...

    Authors: Zahra Goudarzi, Rahil Sadat Shahtaheri, Zhila Najafpour, Haleh Hamedifar and Hamidreza Ebrahimi
    Citation: Cost Effectiveness and Resource Allocation 2024 22:17
  33. The population of older adults continues to grow in Iran, with pharmaceutical costs as a leading driver of household health-related costs. The present study was conducted to estimate the out-of-pocket pharmace...

    Authors: Mehran Faraji, Tahereh Sharifi, Saeed Mohammad-pour, Javad Javan-Noughabi, Ali Aboutorabi, Shaghayegh yousefi and Mihajlo Jakovljevic
    Citation: Cost Effectiveness and Resource Allocation 2024 22:15
  34. The study aimed to examine the direct medical cost and impact of tocilizumab (TOZ) versus adalimumab (ADM) and etanercept (ETC) on reducing the levels of two inflammatory markers (e.g., C-reactive protein (CRP...

    Authors: Areej S. Albahdal, Amjad M. Alotaibi, Miteb A. Alanazi, Norah Abanmy, Monira Alwhaibi and Yazed AlRuthia
    Citation: Cost Effectiveness and Resource Allocation 2024 22:14
  35. Many individuals suffer from normal tension glaucoma (NTG) in China. This study utilized Markov models to evaluate the cost-utility of applying many medications and surgery for mild-stage NTG when disease prog...

    Authors: Di Song and Liwen Wang
    Citation: Cost Effectiveness and Resource Allocation 2024 22:13
  36. There is limited evidence-informed guidance on TISP processes for countries where health technology assessment (HTA) is in a nascent phase. We aimed to explore the range of topic identification, selection and ...

    Authors: Julia Bidonde, Vigdis Lauvrak, Aparna Ananthakrishnan, Pritaporn Kingkaew and Elizabeth F. Peacocke
    Citation: Cost Effectiveness and Resource Allocation 2024 22:12
  37. The treatment of hepatitis C has entered the pan-genotypic era, but the effectiveness is not good for the genotype 3b patients who have a large proportion in China. The guidelines for hepatitis C recommend the...

    Authors: Yusi Tu, Xiangyan Tang, Dachuang Zhou, Hanqiao Shao, Leyi Liang and Wenxi Tang
    Citation: Cost Effectiveness and Resource Allocation 2024 22:11
  38. Preference elicitation is widely used within health economic evaluations to inform coverage decisions. However, coverage decisions involve questions of social justice and it is unclear what role empirical evid...

    Authors: Wolf Rogowski and Jürgen John
    Citation: Cost Effectiveness and Resource Allocation 2024 22:10
  39. Combined serplulimab and chemotherapy demonstrated improved clinical survival outcomes in patients with advanced esophageal squamous cell carcinoma (ESCC) and PD-L1 combined positive scores (CPS) ≥ 1. The pres...

    Authors: Jiahui Li, Chaoqun Xu and Suyun Yuan
    Citation: Cost Effectiveness and Resource Allocation 2024 22:8
  40. Programmed cell death protein 1 (PD-1) monoclonal antibody, pembrolizumab, is a promising drug for platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (NPC). We aimed to assess the cost-effectiv...

    Authors: Jing Nie, Huina Wu, Qian Wu, Lihui Liu, Ke Tang, Shuo Wang and Jiyong Wu
    Citation: Cost Effectiveness and Resource Allocation 2024 22:6
  41. Add-on therapy with tiotropium was cost-effective when added to usual care in patients who remain uncontrolled despite treatment with medium or high-dose ICS/LABA in a middle-income country.

    Authors: Jefferson Antonio Buendía and Diana Guerrero Patiño
    Citation: Cost Effectiveness and Resource Allocation 2024 22:4
  42. Human communities suffered a vast socioeconomic burden in dealing with the pandemic of coronavirus disease 2019 (COVID-19) globally. Real-word data about these burdens can inform governments about evidence-bas...

    Authors: Majid Nakhaee, Masoud Khandehroo and Reza Esmaeili
    Citation: Cost Effectiveness and Resource Allocation 2024 22:3
  43. Access to convenient quality healthcare at all times is considered a basic human right; however, many countries are still striving to achieve this goal for their populations. The persistent rise in healthcare ...

    Authors: Mohammed Khaled Al-Hanawi and Naseem Al Rahahleh
    Citation: Cost Effectiveness and Resource Allocation 2024 22:2
  44. Maternal and neonatal mortality in low- and middle-income countries is frequently caused by inadequate management of obstetric and neonatal complications and a shortage of skilled health workers. The availabil...

    Authors: Chakib Boukhalfa, Brahim Ouakhzan, Hanane Masbah, Leila Acharai and Saad Zbiri
    Citation: Cost Effectiveness and Resource Allocation 2024 22:1
  45. In China, the healthcare financing structure involves multiple parties, including the government, society and individuals. Medicare Fund is an important way for the Government and society to reduce the burden ...

    Authors: Wenqing Wu, Shujie Long, Arcadio A. Cerda, Leidy Y. Garcia and Mihajlo Jakovljevic
    Citation: Cost Effectiveness and Resource Allocation 2023 21:97

Annual Journal Metrics

  • 2022 Citation Impact
    2.3 - 2-year Impact Factor
    2.4 - 5-year Impact Factor
    0.916 - SNIP (Source Normalized Impact per Paper)
    0.530 - SJR (SCImago Journal Rank)

    2023 Speed
    6 days submission to first editorial decision for all manuscripts (Median)
    157 days submission to accept (Median)

    2023 Usage 
    595,859 downloads
    2,584 Altmetric mentions